| Date | Ref. No. | Patent No. | Title |
| 12/3/2012 | E-025-2010/0 | | Nitric Oxide-Based Therapeutics for Lung Cancer |
| 11/21/2012 | E-256-1999/0 | 7,659,081
7,993,857 | Methods for Measuring Adrenomedullin and Monitoring and Treating Adrenomedullin-mediated Diseases, Such as Diabetes and Cancer |
| 11/1/2012 | E-103-2000/0
E-103-2000/1 | 6,753,317
6,916,905 | Novel Dmt-Tic Analogues Specific for Delta- and Mu-Opioid Receptors |
| 10/6/2012 | E-177-2006/0 | 7,553,936 | New Target for the Treatment of Cancer, Infectious Diseases, Cardiac Diseases, and Platelet-Associated Disorders |
| 9/28/2012 | E-043-2008/0 | | Cross-Reactive Neutralizing Human Domain Antibody Against HIV-1 |
| 9/28/2012 | E-043-2008/0
E-103-2010/1
E-322-2008/0 | | Human Antibodies and Fusion Proteins with Potent and Broad HIV-1 Neutralizing Activity |
| 8/1/2012 | E-259-2003/0 | 8,044,057 | Anti-Proliferative Activity of an Unexpected mTOR Kinase Inhibitor |
| 8/1/2012 | E-116-2005/0 | 8,202,551 | Cell-Nanofiber Composite Based Engineered Cartilage |
| 8/1/2012 | E-042-1998/0 | 6,897,018
7,534,565 | DLC-1 Gene Deleted in Cancers |
| 8/1/2012 | E-318-2007/0 | 7,989,630 | Radiotracers for Imaging P-glycoprotein Transporter Function |
| 6/6/2012 | E-064-2008/2 | | Englerin A: A Novel Renal Cancer Therapeutic Isolated from an African Plant |
| 4/30/2012 | E-011-2010/0 | | Parvovirus B19 Codon Optimized Structural Proteins for Vaccine and Diagnostic Applications |
| 4/30/2012 | E-093-2010/0 | | Diagnostic H5N1 Avian Influenza Virus Peptides |
| 3/2/2012 | E-160-2006/0 | 8,008,316 | Potent, Easy to Use Targeted Toxins as Anti-Tumor Agents |
| 2/13/2012 | E-202-2008/0 | | A Novel Treatment for Malarial Infections |
| 6/30/2011 | E-150-2007/0 | | A Novel Therapeutic Strategy for the Treatment of Hyperpigmentation and Melanoma |
| 6/16/2011 | E-289-1999/0 | 6,664,263 | Imidazoacridones with Anti-Tumor Activity |
| 6/1/2011 | E-118-2009/0 | | Novel Diagnostic and Therapeutic Biomarkers for Squamous Cell Carcinomas |
| 4/12/2011 | E-281-2007/0
E-281-2007/1 | | Three-Dimensional Co-Culture Assay System for Angiogenesis and Metastasis |
| 10/29/2010 | E-265-1999/2 | 7,871,981 | Inhibition of Cell Motility, Angiogenesis and Metastasis |
| 10/18/2010 | E-275-2008/2 | | Use of Mono-Amine Oxidase Inhibitors to Prevent Herpes Virus Infections and Reactivation from Latency |
| 9/30/2010 | E-183-2004/1 | | Enriched Natural Killer Cells for Adoptive Infusion Cancer Therapy |
| 6/16/2010 | E-215-2004/0 | | CpG Oligonucleotide Prodrugs |
| 6/16/2010 | E-009-1991/0
E-009-1991/1
E-301-1998/2 | 5,565,424 | Cancer Therapy Using Vasoactive Intestinal Peptide Antagonists |
| 6/16/2010 | E-296-2004/0 | | Novel Form of Interleukin-15, Fc-IL-15, and Methods of Use |
| 6/16/2010 | E-200-2005/0 | | Insect Cell Production of Recombinant Adeno-Associated Virus that Produce Cytotoxic Gene Products and Applications for Solid Tumor Therapy |
| 6/16/2010 | E-105-1999/0 | 7,226,991
7,825,216 | Phenylalanine Derivatives |
| 6/16/2010 | E-286-2006/2 | 8,133,859 | A Novel Growth Factor and Anti-Apoptotic Agent for Promoting Lung Development and Treating Lung Disease |
| 6/16/2010 | E-110-2006/0 | | Muramyl Dipeptide as a Therapeutic Agent for Inflammation |
| 6/16/2010 | E-095-2008/0 | | A Prophylactic and Therapeutic for Preventing and Treating Tularemia by Rapid Activation of Host Cells and Antigen Recognition |
| 6/16/2010 | E-051-2008/0 | | A Novel and Efficient Technology for Targeted Delivery of siRNA |
| 6/16/2010 | E-026-2009/0 | | Recombineering Vector |
| 6/16/2010 | E-182-2008/0 | 8,222,225 | Method of Treating Pneumoconiosis with Oligodeoxynucleotides |
| 6/16/2010 | E-092-2008/0 | | Novel Oligonucleotides for Treatment of Human Cancer |
| 6/16/2010 | E-005-2009/1 | | A Novel System for Producing Infectious Hepatitis C Virus (HCV) Virions and Development of a Novel Reporter System for Studying HCV Entry |
| 6/16/2010 | E-552-1982/2 | 6,998,252
7,015,024
7,045,136
7,045,313 | Recombinant Vaccines Based on Poxvirus Vectors |
| 6/16/2010 | E-217-2001/0
E-264-1997/0 | 6,685,949
7,641,906 | Moraxella Catarrhalis Lipooligosaccharide Based Conjugate Vaccines for the Prevention of Otitis Media and Respiratory Infections |
| 6/16/2010 | E-217-2001/0
E-228-1995/1 | 6,207,157
6,607,725
7,641,906 | Nontypeable Haemophilus Influenzae Lipooligosaccharide Based Conjugate Vaccines for the Prevention of Otitis Media and Respiratory Infections |
| 6/16/2010 | E-243-2002/1 | | Recombinant Vaccinia Viruses Expressing IL-15 and Methods of Using the Same |
| 6/16/2010 | E-090-2003/0 | | Vaccine Peptide Derived from XAGE-1 to Prevent Tumor Growth |
| 6/15/2010 | E-233-2000/0 | 7,052,907 | Adult Human Dental Pulp Stem Cells in vitro and in vivo |
| 6/15/2010 | E-171-1994/0 | 5,780,589 | Application of Highly Potent and Ultraselective delta Opioidmimetic Peptide Antagonists for Biochemical, Pharmacological, Clinical and Therapeutic Studies |
| 6/15/2010 | E-215-2001/0 | 7,666,674 | Use of Sterically Stabilized Cationic Liposomes to Efficiently Deliver CpG Oligonucleotides in vivo |
| 6/14/2010 | E-130-2004/0 | 8,088,787 | Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson’s and Alzheimer’s Disease |
| 6/14/2010 | E-135-2004/0 | | Retinal Pigment Epithelial Cells Immortalized with TERT and Expressing the Adenoviral E1A Oncoprotein |
| 6/14/2010 | E-151-2006/0
E-151-2006/1 | | Viral Entry or Replication Inhibitors |
| 6/14/2010 | E-156-2006/0 | | Beta-Amyloid PET Imaging Agents |
| 6/14/2010 | E-122-2006/0 | | Agonist Epitopes for Renal Cell Carcinoma |
| 6/14/2010 | E-198-2006/0 | | Anti-H5N1 Influenza Activity of the Antiviral Protein Cyanovirin |
| 6/14/2010 | E-200-1998/0 | 7,470,506 | Methods for Treating Drug-Resistant HIV-1 Infection |
| 6/14/2010 | E-098-2007/0 | | Synthetic Macrolides Inhibit Breast Cancer Migration |
| 6/14/2010 | E-158-2007/3 | 8,298,541 | Live Attenuated Virus Vaccines for La Crosse Virus and Other Bunyaviridae |
| 6/14/2010 | E-236-2007/3 | | Immunogenic Peptides Against Influenza Virus |
| 6/14/2010 | E-147-1999/0
E-147-1999/1 | 6,977,245
7,960,356
8,030,285
8,227,446 | Oligodeoxynucleotide and Its Use To Induce an Immune Response |
| 6/14/2010 | E-208-2007/0 | | Eeyarestatins: Novel Deubiquitination Inhibitors for the Treatment of Drug-Resistant Cancers |
| 6/14/2010 | E-166-2007/0 | | Discovery of and Use of Fragments of DOC1 as Antiangiogenic and Antitumor Therapy |
| 6/14/2010 | E-257-2000/0 | 7,163,818 | Bacteriophage Having Multiple Host Range |
| 6/14/2010 | E-146-2008/2 | | Adoptive Immunotherapy for Reestablishing HIV-specific Cytotoxic T-cell (CD8 T-cell) Function in HIV and AIDS Patients and Methods for Assessing the Reestablishment of CD8 T-cell Function |
| 6/14/2010 | E-142-2008/0 | | Humanized Monoclonal Antibodies that Specifically Bind Japanese Encephalitis Virus (JEV) and Their Use |
| 6/14/2010 | E-161-2008/0 | | Anti-Hepatitis C Virus Activity of the Protein Scytovirin (SVN) |
| 6/14/2010 | E-128-2006/0 | | Novel Dopamine Receptor Ligands as Therapeutics for Central Nervous System Disorders |
| 6/14/2010 | E-315-2003/0 | 7,767,645 | SH2 Domain Binding Inhibitors (E-315-2003) |
| 6/14/2010 | E-089-2009/0 | | Immunogenic Tumor-associated Antigen SPANX-B for Selective Cancer Immunotherapy |
| 6/14/2010 | E-273-2009/0 | 8,383,099 | Simpler is Better: The Production of Young Cell Cultures from Tumor Infiltrating Lymphocytes (TIL) Yields More Effective Adoptive Cell Transfer (ACT) Immunotherapies |
| 6/14/2010 | E-201-1998/0 | | Immunotoxin Useful for Treatment of AIDS |
| 6/14/2010 | E-243-2009/0 | | Defensin-Based Therapeutics for the Treatment of Pulmonary Disease |
| 6/14/2010 | E-088-2007/1
E-172-2009/0 | | Zscan4, a Therapeutic Target for Cancer, Regenerative Medicine and Aging |
| 6/14/2010 | E-153-2008/0 | | Radioprotectants and Tumor Radiosensitizers Targeting Thrombospondin-1 and CD47 |
| 6/14/2010 | E-225-2009/0 | | Parkin and PINK1-Based Therapies for Parkinson's Disease and Other Mitochondrial Diseases |
| 6/14/2010 | E-301-1998/0
E-301-1998/1
E-301-1998/2 | | Combination Therapy With VIP Antagonists |
| 6/14/2010 | E-222-2000/0 | | Novel Inhibitors of p53 for Treatment of Neurodegenerative Disorders, Myocardial Infarction and Other Tissue Insults |
| 6/14/2010 | E-337-2001/0 | 1446158
7,368,114 | A Novel Multimeric CD4 Fusion Protein for Treating HIV Infection |
| 6/14/2010 | E-317-2001/0 | | Discovery of Novel Inhibitors of HIV-1 Integrase That Can Be Used for the Treatment of Retroviral Infection Including AIDS |
| 6/14/2010 | E-132-1994/0 | 5,942,230
6,197,528 | Retinoids Can Increase the Potency of Anti-Cancer Immunotoxins |
| 6/14/2010 | E-135-2002/1 | 7,470,775 | Novel Anti-CD30 Antibodies and Recombinant Immunotoxins Containing Disulfide-Stabilized Fv Fragments |
| 6/14/2010 | E-191-2002/0 | 7,205,334
7,521,475
8,278,348 | Chondropsin-Class Antitumor V-ATPase Inhibitor Compounds, Compositions and Methods of Use Thereof |
| 6/14/2010 | E-163-2002/2 | 8,008,463 | Diagnostics and Therapeutics for Hydrocephalus |
| 6/14/2010 | E-230-2002/2 | 7,482,133 | Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use |
| 6/14/2010 | E-191-2003/1 | | Eosinophil-Derived Neurotoxin, an Antimicrobial Protein with Ribonuclease Activity, is an Immunostimulant |
| 6/14/2010 | E-230-2000/0 | 6,596,690
7,432,236
7,812,117 | Vasostatin as Marrow Protectant |
| 6/14/2010 | E-189-1998/0 | | Inhibitors of Formation of Protease Resistant Prion Protein |
| 6/14/2010 | E-091-2003/0 | | Methods for the Treatment of Parkinson's Disease and Other alpha-synucleinopathies |
| 6/14/2010 | E-236-2003/0 | | Retrovirus-Like Particles as Vaccines and Immunogens |
| 6/14/2010 | E-223-2003/1 | 8,163,542 | Improved Expression Vectors for Mammalian Use |
| 6/14/2010 | E-247-2002/1 | | Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis) |
| 6/14/2010 | E-187-2003/0 | 7,776,883 | Quinoline Inhibitors of Retroviral Integrase |
| 6/14/2010 | E-291-2003/0 | | New Building Blocks for DNA Binding Agents |
| 6/10/2010 | E-041-2000/0 | 6,448,245 | HIV Protease Inhibitors, Ritonavir and Saquinavir are Potent Inhibitors of Calcium Activated Neutral Peptidases, Calpains |
| 6/10/2010 | E-013-2006/1 | | Antiviral Compounds with Broad Neutralization Capabilities |
| 6/10/2010 | E-080-2006/0 | 8,143,252 | A New Series of Thalidomide Analogs That Have Potent Anti-Angiogenic Properties |
| 6/10/2010 | E-040-1993/0 | 5,833,986
5,863,739 | Neutralizing Monoclonal Antibody To Human Alpha PDGF Receptors |
| 6/10/2010 | E-014-2007/0 | 8,198,402 | Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents |
| 6/10/2010 | E-062-1996/0
E-099-1996/0
E-154-1998/0
E-200-1990/3
E-200-1990/4
E-256-1998/0
E-259-1994/3
E-259-1994/4
E-260-1994/1 | 6,001,349
6,045,802
6,165,460
6,319,496
6,548,068
6,756,038
6,893,869
6,946,133
6,969,609
7,118,738
7,211,432
7,368,116
7,410,644
7,547,773
7,598,225
7,662,395
7,723,096
7,771,715
7,871,986
8,178,508 | Enhanced T-cell Activation by Costimulation: An Effective Immunotherapy for Cancer and Infectious Diseases |
| 6/10/2010 | E-074-2007/0 | 8,188,214 | Human T-box Transcription Factor Brachyury as a Target for Cancer Immunotherapy: Identification of Epitopes of Human Brachyury as Targets for T-cell Mediated Lysis of Tumors |
| 6/10/2010 | E-055-2007/3 | | Inhibiting HIV Infection Using Integrin Antagonists |
| 6/10/2010 | E-012-2008/0 | | C4'-Substituted-2-Deoxyadenosine Analogs and Methods of Treating HIV |
| 6/10/2010 | E-008-1996/0 | | C-C Chemokines That Inhibit Retrovirus Infection |
| 6/10/2010 | E-082-1998/0 | 6,867,180
7,488,711 | Use Of Calreticulin And Calreticulin Fragments To Inhibit Endothelial Cell Growth And Angiogenesis, And Suppress Tumor Growth |
| 6/10/2010 | E-007-2004/0 | 7,511,032
7,834,005 | Adduct Compounds of Pyrrolobenzodiazepinones, Compositions Comprising the Same and Methods Related Thereto |
| 6/3/2010 | E-287-2000/0 | | Cell-Free Assembly of Lentiviral Capsids |
| 6/3/2010 | E-216-1994/0 | 6,057,346 | Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers |